Sort by
Refine Your Search
-
Listed
-
Program
-
Employer
- ;
- University of Exeter
- Medical Research Council
- University of Oxford
- University of London
- ; The Francis Crick Institute
- Cardiff University
- KINGS COLLEGE LONDON
- NATA
- QUEENS UNIVERSITY BELFAST
- Queen's University Belfast
- UNIVERSITY OF SOUTHAMPTON
- University of Leeds
- University of Nottingham
- 4 more »
- « less
-
Field
-
partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL (University College London), Imperial College London and King’s College London. The Crick was formed in 2015, and in 2016 it
-
part of a multinational Medical Research Council (UK) and JPIAMR funded project involving academic and medical collaborative partners in the UK, continental Europe and Africa with the aim of improving
-
the role of genetic and environmental factors in physical and mental health multimorbidity development. You will join a consortium of researchers funded by a £3,632,000 grant from the Medical Research
-
the UK Medical Research Council and is available immediately. The salary will be on the Academic Pathway salary scale, Grade 6 in the range £43,947-£49,908 per annum (inclusive of London Weighting
-
Therapy Accelerator The Medical Research Council (MRC), as part of UK Research and Innovation (UKRI), have invested a total of £30m over 4 years through the Strategic Priorities Fund to establish a nucleic
-
About the job: The postholder will deliver the exciting project funded by UK Medical Research Council which involves process development of extracellular vesicles-based therapy manufacturing as
-
this project will directly work with research teams developing and testing new vaccines. The Medical Research Council (MRC) Centre for Global Infectious Disease Analysis is an international resource and centre
-
laboratory is multidisciplinary and international, with sustained high-quality productivity. Our work is generously supported by funding from the Medical Research Council, and an ERC Advanced Grant to the PI
-
Accelerator The Medical Research Council (MRC), as part of UK Research and Innovation (UKRI), have invested a total of £30m over 4 years through the Strategic Priorities Fund to establish a nucleic acid therapy
-
Nucleic Acid Therapy Accelerator The Medical Research Council (MRC), as part of UK Research and Innovation (UKRI), have invested a total of £30m over 4 years through the Strategic Priorities Fund